Faculty Information - HORIUCHI Kiyomi

■ Published papers

1.	Original article	Reevaluation of urinary calcium excretion as a criterion for surgery in primary hyperparathyroidism: a study on nephrolithiasis risk 2026/06
2.	Original article	Parathyroid Carcinoma Disseminated Following Endoscopically-Assisted Surgery: A Case Report 2026/04/19
3.	Original article	Advanced disease and biochemical phenotype shift in multiple endocrine neoplasia type 2A-related pheochromocytoma 2026/03/12
4.	Original article	Discordance of intrinsic subtype between primary tumor and lymph node metastasis in breast cancer patients 2026/03
5.	Original article	Reliability of CT attenuation value for adrenal masses 2026/02/20
6.	Original article	Fascin expression is associated with aggressive clinicopathological features in parathyroid tumors 2026/02/11
7.	Original article	Outcome of Thoracoscopic Surgery for Ectopic Mediastinal Parathyroid Tumor 2026/01/13
8.	Original article	Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach 2025/07/03
9.	Review article	ACTIVE SURVEILLANCE FOR APILLARY THYROID MICROCARCINOMA ―PAST, PRESENT, AND FUTURE― 2025/07
10.	Original article	Predicting Tumor Volume in Primary Hyperparathyroidism From Preoperative Clinical Data 2025/01/21
11.	Original article	Outcomes of Patients with an Intermediate-Risk Group According to the Japanese Risk Classification of Papillary Thyroid Carcinoma 2023/06
12.	Original article	Predictive value of metastatic lateral lymph node ratio for recurrence in pathologically lateral lymph node-positive papillary thyroid cancer patients with palpable lymph nodes 2022/07
13.	Case report	A case of tertiary hyperparathyroidism due to hypophosphatemic rickets 2022/02/25
14.	Case report	Papillary thyroid microcarcinoma with multiple pulmonary metastases following lung cancer surgery: a case report 2022
15.	Review article	Radioactive iodine treatment of papillary thyroid carcinoma in Japan 2020/05
16.	Original article	Low‑dose radioiodine therapy for patients with intermediate‑ to high‑risk differentiated thyroid cancer 2019/12/13
17.	Review article	International comparison of papillary thyroid carcinoma treatment according to clinical guidelines -　Postoperative adjuvant therapy - 2019
18.	Original article	Impact of Tailored parathyroidectomy for treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 2018
19.	Original article	Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up 2018
20.	Case report	Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case. 2017/12
21.	Original article	safety and tolerability of vandetanib in japanese patients with medullary thyroid cancer: a phase I/II open-label study 2017/02
22.	Original article	An analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution 2013
23.	Original article	clinical features of insulinoma in patients with multiple endocrine neoplasia type1: analysis of the database pf the MEN consortium pf Japan 2012/06
24.	Original article	delay in the diagnosis of multiple endocrine neoplasia type 1: typical symptms are frequently overlooked 2012/02
25.	Original article	multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database 2012
26.	Case report	A rare case of hereditary medullary thyroid cancer with mutation of codon 804 in exon 14 of the RET protp-oncogene. 2008/03
27.	Original article	Usefulness and indication of 99m Tc-methoxyisobutylisonitrile(MIBI) for preoperative localization in patients with primary hyperparathyroidism 1997
Display 5 items
Display all(27)

■ Academic conference presentation

1.	Reliability of CT attenuation value for adrenal masses （Poster notice，General） 2026/06/04
2.	Preoperative Diagnosis of Thyroid Cancer （Speech，Panelist at Symposium/Workshop (Appointed)） 2026/03/20
3.	A case of decreased urinary metanephrines resulting from reduced serum catecholamines in a patient with multiple endocrine neoplasia type 2B treated with selpercatinib （Poster notice，General） 2025/04/03
4.	Practical guideline and changes for diagnosis and treatment of adrenal incidentaloma （Speech，Panelist at Symposium/Workshop (Appointed)） 2025/04/03
5.	HOW WILL NEWLY DEVELOPING TARGETED THERAPIES CHANGE THE SEQUENCE OF THYROID CANCER MANAGEMENT? AN ENDOCRINE SURGEON’S PERSPECTIVE （Speech，Panelist at Symposium/Workshop (Appointed)） 2024/08/29
6.	Reevaluating surgical indications for asymptomatic primary hyperparathyroidism: hypercalciuria is not a urinary stone risk （Poster notice，General） 2024/08/27
7.	The frequency of postoperative hypoglycemia after pheochromocytoma surgery is decreasing （Speech，General） 2024/08/27
8.	The postoperative clinical course of pheochromocytoma in patients with multiple endocrine neoplasia type2 (MEN2) （Poster notice，General） 2024/08/27
9.	Surgery for primary hyperparathyroidism in MEN1 （Speech，General） 2023/03/17
10.	Impact of urinary calcium excretion on urinary stones primary hyperparathyroidism （Poster notice，General） 2023/03/16
11.	Predicting tumor volume in primary hyperparathyroidism from preoperative clinical data （Poster notice，General） 2023/03/16
12.	Quality of life in patients with primary hyperparathyroidism without surgery （Speech，General） 2023/03/16
13.	Lateral neck dissection （Speech，Panelist at Symposium/Workshop (Appointed)） 2020/03/07
14.	Treatment outcomes of papillary thyroid carcinoma following the Japanese guidelines for the management of thyroid tumors 2020 （Poster notice，General） 2019/10/31
15.	Mulifocal papillary thyroid carcinoma : is completion thyroidectomy necessary to improve the prognosis? （Poster notice，General） 2019/08/11
16.	Report of MEN1 Registry of Japan. 2018/03/08
17.	Prognosis and prognostic factors for cancer mortality in patients with lymph node metastases from papillary thyroid carcinoma as a first-time recurrence （Poster notice，General） 2017/10/19
18.	Prediction of malignancy in thyroid nodules with macrocalcification by ultrasonography （Poster notice，General） 2017/09/09
19.	Impact of risk classification of papillary thyroid carcinoma based on the Japanese clinical guideline and prognostic factors in gray zone （Poster notice，General） 2017/08/14
20.	CLINICOPATHOLOGICAL CHARACTERISTICS OF FALSE NEGATIVE CASES IN FDG-PET/CT SCAN PERFORMED AS PREOPERATIVE AXILLARY ASSESSMENT FOR INVASIVE BREAST CANCER （Poster notice） 2017/08
21.	What treatment should be selected to obtain longer time to treatment failure (TTF) in HER2 negative metastatic breast cancer: the evaluation of the impact of agents on prognosis （Poster notice） 2017/08
22.	The current treatment of primary hyperparathyroidism in MEN1 in Japan: the analysis of data from MEN consortium of Japan. （Speech，Panelist at Symposium/Workshop (Appointed)） 2016/10/24
23.	Use of Fulvestrant for inoperable/recurrent breast cancer patients in our hospital （Speech，Panelist at Symposium/Workshop (Other)） 2016/10/22
24.	The current treatment for primary hyperparathyroidism in MEN1 in Japan: the analysis of data from MEN Consortium of Japan （Speech，General） 2016/10/01
25.	Parathyroid carcinoma in MEN1:report of a case （Poster notice，General） 2016/09/30
26.	Long-term prognosis of advanced papillary thyroid carcinoma with extra-thyroidal extension: Role of "shaving-off" resection （Speech，General） 2016/04/08
27.	Correlation of immediate reconstruction with clinical outcome to locally advanced breast cancer （Poster notice，General） 2015/12/20
28.	Predicting no metastases to axillary lymph nodes beyond positive sentinel nodes in patients with breast cancer: a simple rule （Poster notice，General） 2015/12/20
29.	Factors associated with long-term biochemical cure after surgical treatment of hereditary medullary thyroid carcinoma(HMTC) （Poster notice，General） 2015/10/20
30.	Clinical outocomes of individualized approarch of parathyroidectomy to patients with primary hyperparathyroidism(PHPT) in multiple endocrine neoplasia type 1(MEN1):the experienced at a single institution （Poster notice，General） 2014/09/26
31.	Cinacalcet has a limited effect in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: a case report （Poster notice，General） 2013/09/21
Display 5 items
Display all(31)

■ Qualifications & licenses

1.

2021/05/01

Board-certified Senior Doctor Member of the Japanese Society for Hereditary Tumors

■ Research areas

General surgery and pediatric surgery

■ Awards & honors

1.

2007/08

International Association of Endocrine Surgery IAES　poster　prize

■ Academic society memberships

1.

2023～

International　Association of Endocrine Surgeons

■ Education

1.

1987/04～1992/03

Faculty of Medicine, Tokyo Women's Medical University, Graduated

■ Academic & professional experience

1.	2022/02	Tokyo　Women's　Medical University Endocrine　Surgery Associate Professor
2.	2000/04～2007/03	Research Assistant